MATTHEWBRAMSMATTHEW BRAMS29.76689480000000-95.421522400000003181BRAMS, MATTHEWClinical Assistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonPharmaceutical Health Outcomes and PolicyAuthorship 355292Palliative Care & Rehabilitation MedicineMD AndersonEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorAuthorship 750541550 Westcott, #520Houston, 77007TX74Professor27Clinical Assistant Professor14Associate Professor21904087Mao AR, Brams M, Babcock T, Madhoo MPostgraduate medicineA physician's guide to helping patients with ADHD find success in the workplace. Postgrad Med. 2011 Sep; 123(5):60-70.Postgrad Med2011-09-01T00:00:002011A physician's guide to helping patients with ADHD find success in the workplace.18176337Silva RR, Muniz R, Pestreich L, Brams M, Mao AR, Childress A, Wang JJournal of the American Academy of Child and Adolescent PsychiatryDexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):199-208.J Am Acad Child Adolesc Psychiatry2008-02-01T00:00:002008Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.18362868Silva R, Muniz R, McCague K, Childress A, Brams M, Mao APsychopharmacology bulletinTreatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting. Psychopharmacol Bull. 2008; 41(1):19-33.Psychopharmacol Bull2008-01-01T00:00:002008Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting.18582179Muniz R, Brams M, Mao A, McCague K, Pestreich L, Silva RJournal of child and adolescent psychopharmacologyEfficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study. J Child Adolesc Psychopharmacol. 2008 Jun; 18(3):248-56.J Child Adolesc Psychopharmacol2008-06-01T00:00:002008Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study.22926597Brams M, Turnbow J, Pestreich L, Giblin J, Childress A, McCague K, Muniz RJournal of clinical psychopharmacologyA randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control. J Clin Psychopharmacol. 2012 Oct; 32(5):637-44.J Clin Psychopharmacol2012-10-01T00:00:002012A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control.Authorship 877283128816509Brams M, Childress AC, Greenbaum M, Yu M, Yan B, Jaffee M, Robertson BJournal of child and adolescent psychopharmacologySHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study. J Child Adolesc Psychopharmacol. 2018 02; 28(1):19-28.J Child Adolesc Psychopharmacol2017-08-17T00:00:002017SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.18601306Brams M, Muniz R, Childress A, Giblin J, Mao A, Turnbow J, Borrello M, McCague K, Lopez FA, Silva RCNS drugsA randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect. CNS Drugs. 2008; 22(8):693-704.CNS Drugs2008-01-01T00:00:002008A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.18824827Brams M, Mao AR, Doyle RLPostgraduate medicineOnset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgrad Med. 2008 Sep; 120(3):69-88.Postgrad Med2008-09-01T00:00:002008Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.20491612Brams M, Moon E, Pucci M, L?pez FACurrent medical research and opinionDuration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr Med Res Opin. 2010 Aug; 26(8):1809-25.Curr Med Res Opin2010-08-01T00:00:002010Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.21775825Mao AR, Babcock T, Brams MJournal of psychiatric practiceADHD in adults: current treatment trends with consideration of abuse potential of medications. J Psychiatr Pract. 2011 Jul; 17(4):241-50.J Psychiatr Pract2011-07-01T00:00:002011ADHD in adults: current treatment trends with consideration of abuse potential of medications.Authorship 8779214Authorship 8780125Authorship 8782032Authorship 8782553Authorship 8782864Authorship 8783122Authorship 8783132Authorship 8783361Authorship 8783372Authorship 8783755Authorship 8784112Authorship 8784172Authorship 8784184Authorship 8784273Authorship 8784872Authorship 8785091Authorship 8785594Authorship 8785682Authorship 8786082Authorship 8787012Authorship 8788114Authorship 883430316190795Silva R, Muniz R, Pestreich LK, Brams M, Childress A, Lopez FAJournal of child and adolescent psychopharmacologyEfficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):637-54.J Child Adolesc Psychopharmacol2005-08-01T00:00:002005Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.16768632Silva RR, Muniz R, Pestreich L, Childress A, Brams M, Lopez FA, Wang JJournal of child and adolescent psychopharmacologyEfficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):239-51.J Child Adolesc Psychopharmacol2006-06-01T00:00:002006Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.20576091Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J, 316 Study GroupBehavioral and brain functions : BBFRandomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct. 2010 Jun 24; 6:34.Behav Brain Funct2010-06-24T00:00:002010Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.20858786Findling RL, Brams M, Childress AC, L?pez FA, Manos MJ, Jensen PSJournal of attention disordersChanges in emotions related to medication used to treat ADHD. Part II: clinical approaches. J Atten Disord. 2011 Feb; 15(2):113-21.J Atten Disord2010-09-21T00:00:002010Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches.20861583Brown TE, Brams M, Gao J, Gasior M, Childress APostgraduate medicineOpen-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Postgrad Med. 2010 Sep; 122(5):7-17.Postgrad Med2010-09-01T00:00:002010Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.20876887Manos MJ, Brams M, Childress AC, Findling RL, L?pez FA, Jensen PSJournal of attention disordersChanges in emotions related to medication used to treat ADHD. Part I: literature review. J Atten Disord. 2011 Feb; 15(2):101-12.J Atten Disord2010-09-28T00:00:002010Changes in emotions related to medication used to treat ADHD. Part I: literature review.21488750Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HLJournal of child and adolescent psychopharmacologyAcademic, behavioral, and cognitive effects of OROS? methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Apr; 21(2):121-31.J Child Adolesc Psychopharmacol2011-04-13T00:00:002011Academic, behavioral, and cognitive effects of OROS? methylphenidate on older children with attention-deficit/hyperactivity disorder.21474905Wigal T, Brams M, Gasior M, Gao J, Giblin JPostgraduate medicineEffect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Postgrad Med. 2011 Mar; 123(2):169-76.Postgrad Med2011-03-01T00:00:002011Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.21555501Kollins SH, Jain R, Brams M, Segal S, Findling RL, Wigal SB, Khayrallah MPediatricsClonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics. 2011 Jun; 127(6):e1406-13.Pediatrics2011-05-09T00:00:002011Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.21973229Brown TE, Brams M, Gasior M, Adeyi B, Babcock T, Dirks B, Scheckner B, Wigal TCurrent medical research and opinionClinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults. Curr Med Res Opin. 2011; 27 Suppl 2:23-33.Curr Med Res Opin2011-01-01T00:00:002011Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.21566420Brams M, Giblin J, Gasior M, Gao J, Wigal TPostgraduate medicineEffects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD. Postgrad Med. 2011 May; 123(3):99-108.Postgrad Med2011-05-01T00:00:002011Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD.22780921Brams M, Weisler R, Findling RL, Gasior M, Hamdani M, Ferreira-Cornwell MC, Squires LThe Journal of clinical psychiatryMaintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design. J Clin Psychiatry. 2012 Jul; 73(7):977-83.J Clin Psychiatry2012-06-12T00:00:002012Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.23860345Silva RR, Brams M, McCague K, Pestreich L, Muniz RClinical neuropharmacologyExtended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder. Clin Neuropharmacol. 2013 Jul-Aug; 36(4):117-21.Clin Neuropharmacol2013-07-01T00:00:002013Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder.24529610Weiden PJ, Citrome L, Alva G, Brams M, Glick ID, Jackson R, Mattingly G, Kianifard F, Meng X, Pestreich L, Hochfeld M, Winseck ASchizophrenia researchA trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia. Schizophr Res. 2014 Mar; 153(1-3):160-8.Schizophr Res2014-02-12T00:00:002014A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia.25295648Weisler RH, Babcock T, Adeyi B, Brams MPostgraduate medicineRelationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate. Postgrad Med. 2014 Sep; 126(5):31-41.Postgrad Med2014-09-01T00:00:002014Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.25692608Childress AC, Brams M, Cutler AJ, Kollins SH, Northcutt J, Padilla A, Turnbow JMJournal of child and adolescent psychopharmacologyThe Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study. J Child Adolesc Psychopharmacol. 2015 Jun; 25(5):402-14.J Child Adolesc Psychopharmacol2015-02-18T00:00:002015The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.29211967Childress AC, Wigal SB, Brams MN, Turnbow JM, Pincus Y, Belden HW, Berry SAJournal of child and adolescent psychopharmacologyEfficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2018 06; 28(5):306-313.J Child Adolesc Psychopharmacol2017-12-06T00:00:002017Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.ERICSTORCHERIC STORCH13665STORCH, ERICProfessortrue1ProfessorProfessortrue1ProfessorProfessorD000697Chemicals & Drugs972250.849476Central Nervous System StimulantsD008774Chemicals & Drugs381030.921476MethylphenidateD003913Chemicals & Drugs9180.980788DextroamphetamineAuthorship 924732229809075Wigal T, Brams M, Frick G, Yan B, Madhoo MPostgraduate medicineA randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design. Postgrad Med. 2018 Jun; 130(5):481-493.Postgrad Med2018-06-18T00:00:002018A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.D001289Disorders1272730.763484Attention Deficit Disorder with HyperactivityDepartment of PediatricsDepartment of Psychiatry & Behavioral SciencesPsychiatry & Behavioral SciencesPediatrics-NutritionBaylor College of MedicineUniversity of Houston College of PharmacyTHOMASKOSTENTHOMAS KOSTEN0.000000000000000.000000000000001040KOSTEN, THOMASProfessor6.513810.0122755101research areas0.8065160.8065161coauthor of49.45874.4410560similar to1134selected publicationsALICEMAOALICE MAO29.76408160000000-95.411199400000003183MAO, ALICEProfessorRAJENDERAPARASURAJENDER R. APARASU29.70508570000000-95.401808700000004604APARASU, RAJENDERProfessorD064699Chemicals & Drugs2120.986718Dexmethylphenidate Hydrochloride22176941Wilens TE, Bukstein O, Brams M, Cutler AJ, Childress A, Rugino T, Lyne A, Grannis K, Youcha SJournal of the American Academy of Child and Adolescent PsychiatryA controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jan; 51(1):74-85.e2.J Am Acad Child Adolesc Psychiatry2011-11-25T00:00:002011A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.Authorship 954623631464511Childress AC, Cutler AJ, Marraffino A, McDonnell MA, Turnbow JM, Brams M, DeSousa NJ, Incledon B, Sallee FR, Wigal SBJournal of child and adolescent psychopharmacologyA Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings. J Child Adolesc Psychopharmacol. 2020 02; 30(1):2-14.J Child Adolesc Psychopharmacol2019-08-29T00:00:002019A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.true1ProfessorProfessorAuthorship 1003343233090921Childress AC, Brams MN, Cutler AJ, Donnelly GAE, Bhaskar SJournal of child and adolescent psychopharmacologyEfficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study. J Child Adolesc Psychopharmacol. 2020 12; 30(10):580-589.J Child Adolesc Psychopharmacol2020-10-22T00:00:002020Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.Authorship 1032691934714120Kollins SH, Braeckman R, Guenther S, Barrett AC, Mickle TC, Oh C, Marraffino A, Cutler AJ, Brams MNJournal of child and adolescent psychopharmacologyA Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2021 11; 31(9):597-609.J Child Adolesc Psychopharmacol2021-10-29T00:00:002021A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder.Authorship 1180111true1Clinical Assistant ProfessorClinical Assistant ProfessorAuthorship 1070503536809150Childress AC, Marraffino A, Cutler AJ, Oh C, Brams MNJournal of child and adolescent psychopharmacologySafety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. J Child Adolesc Psychopharmacol. 2023 03; 33(2):51-58.J Child Adolesc Psychopharmacol2023-02-20T00:00:002023Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorALEXISWOODALEXIS WOOD7097WOOD, ALEXISAssociate ProfessorAuthorship 39955125245353Cutler AJ, Brams M, Bukstein O, Mattingly G, McBurnett K, White C, Rubin JJournal of the American Academy of Child and Adolescent PsychiatryResponse/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2014 Oct; 53(10):1092-101.J Am Acad Child Adolesc Psychiatry2014-08-15T00:00:002014Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.Authorship 945551Authorship 74053